The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Barker, Carl
    Director born in March 1986
    Individual (12 offsprings)
    Officer
    2024-09-05 ~ now
    OF - Director → CIF 0
  • 2
    Degoes, Jason Jon, Director
    Executive born in November 1969
    Individual (15 offsprings)
    Officer
    2021-06-30 ~ now
    OF - Director → CIF 0
  • 3
    SHOO 588 LIMITED - 2013-12-09
    Olliver, Aske, Richmond, North Yorkshire, England
    Active Corporate (3 parents, 7 offsprings)
    Person with significant control
    2021-03-01 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 9
  • 1
    Mcconnel, Carol
    Director Of Regulatory Affairs born in October 1962
    Individual
    Officer
    2010-01-01 ~ 2010-05-31
    OF - Director → CIF 0
  • 2
    Deonanan, Karl Vishnu
    Chief Financial Officer born in May 1972
    Individual (4 offsprings)
    Officer
    2023-07-15 ~ 2024-08-28
    OF - Director → CIF 0
    Deonanan, Karl
    Individual (4 offsprings)
    Officer
    2023-07-15 ~ 2024-08-28
    OF - Secretary → CIF 0
  • 3
    Barker, Carl
    Director born in March 1986
    Individual (12 offsprings)
    Officer
    2020-07-24 ~ 2021-03-01
    OF - Director → CIF 0
    Barker, Carl
    Individual (12 offsprings)
    Officer
    2019-12-23 ~ 2021-03-01
    OF - Secretary → CIF 0
  • 4
    Sherman, Dawn Gail
    Chief Executive Officer born in August 1967
    Individual (3 offsprings)
    Officer
    2021-03-01 ~ 2023-07-06
    OF - Director → CIF 0
  • 5
    Stomberg, Michael, Chief Executive Officer
    Chief Executive born in August 1967
    Individual (2 offsprings)
    Officer
    2022-08-02 ~ 2024-04-29
    OF - Director → CIF 0
  • 6
    Josephs, John Alexander
    New Business Director born in February 1939
    Individual (1 offspring)
    Officer
    2005-05-24 ~ 2021-03-01
    OF - Director → CIF 0
  • 7
    Josephs, Maureen, Dr
    Regulatory Affairs born in January 1957
    Individual
    Officer
    2005-05-24 ~ 2021-03-01
    OF - Director → CIF 0
    Josephs, Maureen, Dr
    Regulatory Affairs
    Individual
    Officer
    2005-05-24 ~ 2019-12-23
    OF - Secretary → CIF 0
    Dr Maureen Josephs
    Born in January 1957
    Individual
    Person with significant control
    2017-05-01 ~ 2021-03-01
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 8
    Bauwens, Timothy Joseph
    Executive born in October 1966
    Individual (3 offsprings)
    Officer
    2021-06-30 ~ 2024-04-29
    OF - Director → CIF 0
  • 9
    Chestnut, Robert Hugh
    Executive born in May 1961
    Individual
    Officer
    2021-03-01 ~ 2021-06-29
    OF - Director → CIF 0
parent relation
Company in focus

DIAMOND BIOPHARM LIMITED

Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Average Number of Employees
332020-06-01 ~ 2021-03-01
332019-06-01 ~ 2020-05-31
Property, Plant & Equipment
438,306 GBP2021-03-01
489,259 GBP2020-05-31
Fixed Assets - Investments
90 GBP2021-03-01
90 GBP2020-05-31
Fixed Assets
438,396 GBP2021-03-01
489,349 GBP2020-05-31
Debtors
Current
1,304,825 GBP2021-03-01
1,161,057 GBP2020-05-31
Cash at bank and in hand
2,079,077 GBP2021-03-01
1,175,269 GBP2020-05-31
Current Assets
3,383,902 GBP2021-03-01
2,336,326 GBP2020-05-31
Creditors
Current, Amounts falling due within one year
-1,271,851 GBP2021-03-01
-404,882 GBP2020-05-31
Net Current Assets/Liabilities
2,112,051 GBP2021-03-01
1,931,444 GBP2020-05-31
Total Assets Less Current Liabilities
2,550,447 GBP2021-03-01
2,420,793 GBP2020-05-31
Net Assets/Liabilities
2,492,617 GBP2021-03-01
2,358,868 GBP2020-05-31
Equity
Called up share capital
100 GBP2021-03-01
100 GBP2020-05-31
100 GBP2019-06-01
Retained earnings (accumulated losses)
2,492,517 GBP2021-03-01
2,358,768 GBP2020-05-31
2,086,011 GBP2019-06-01
Equity
2,492,617 GBP2021-03-01
2,358,868 GBP2020-05-31
2,086,111 GBP2019-06-01
Profit/Loss
Retained earnings (accumulated losses)
-201,293 GBP2020-06-01 ~ 2021-03-01
820,513 GBP2019-06-01 ~ 2020-05-31
Profit/Loss
-201,293 GBP2020-06-01 ~ 2021-03-01
820,513 GBP2019-06-01 ~ 2020-05-31
Dividends Paid
Retained earnings (accumulated losses)
-547,756 GBP2019-06-01 ~ 2020-05-31
Dividends Paid
-547,756 GBP2019-06-01 ~ 2020-05-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
152020-06-01 ~ 2021-03-01
Furniture and fittings
152020-06-01 ~ 2021-03-01
Computers
252020-06-01 ~ 2021-03-01
Property, Plant & Equipment - Gross Cost
Plant and equipment
4,400 GBP2021-03-01
4,400 GBP2020-05-31
Furniture and fittings
734,150 GBP2021-03-01
726,566 GBP2020-05-31
Computers
144,865 GBP2021-03-01
137,438 GBP2020-05-31
Property, Plant & Equipment - Gross Cost
883,415 GBP2021-03-01
868,404 GBP2020-05-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
3,245 GBP2020-05-31
Furniture and fittings
276,525 GBP2020-05-31
Computers
99,375 GBP2020-05-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
379,145 GBP2020-05-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
130 GBP2020-06-01 ~ 2021-03-01
Furniture and fittings, Owned/Freehold
51,431 GBP2020-06-01 ~ 2021-03-01
Computers, Owned/Freehold
14,403 GBP2020-06-01 ~ 2021-03-01
Owned/Freehold
65,964 GBP2020-06-01 ~ 2021-03-01
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
3,375 GBP2021-03-01
Furniture and fittings
327,956 GBP2021-03-01
Computers
113,778 GBP2021-03-01
Property, Plant & Equipment - Accumulated Depreciation & Impairment
445,109 GBP2021-03-01
Property, Plant & Equipment
Plant and equipment
1,025 GBP2021-03-01
1,155 GBP2020-05-31
Furniture and fittings
406,194 GBP2021-03-01
450,041 GBP2020-05-31
Computers
31,087 GBP2021-03-01
38,063 GBP2020-05-31
Investments in Subsidiaries
90 GBP2021-03-01
90 GBP2020-05-31
Trade Debtors/Trade Receivables
Current
589,915 GBP2021-03-01
634,351 GBP2020-05-31
Amounts Owed by Group Undertakings
Current
615,786 GBP2021-03-01
273,400 GBP2020-05-31
Other Debtors
Current
44,273 GBP2021-03-01
173,176 GBP2020-05-31
Prepayments/Accrued Income
Current
54,851 GBP2021-03-01
80,130 GBP2020-05-31
Trade Creditors/Trade Payables
Current
1,101,224 GBP2021-03-01
86,503 GBP2020-05-31
Corporation Tax Payable
Current
7,464 GBP2021-03-01
Taxation/Social Security Payable
Current
98,846 GBP2021-03-01
114,099 GBP2020-05-31
Other Creditors
Current
2,242 GBP2021-03-01
3,091 GBP2020-05-31
Accrued Liabilities/Deferred Income
Current
62,075 GBP2021-03-01
201,189 GBP2020-05-31
Creditors
Current
1,271,851 GBP2021-03-01
404,882 GBP2020-05-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2021-03-01
100 shares2020-05-31
Par Value of Share
Class 1 ordinary share
1.002020-06-01 ~ 2021-03-01
Related profiles found in government register
  • DIAMOND BIOPHARM LIMITED
    Info
    Registered number 05460964
    Olliver, Aske, Richmond, North Yorkshire DL10 5HX
    Private Limited Company incorporated on 2005-05-24 (20 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-05-24
    CIF 0
  • DIAMOND BIOPHARM LIMITED
    S
    Registered number 05460964
    Suite 2, Ground Floor Field House, Station Approach, Harlow, England, CM20 2FB
    Limited By Shares in Companies House, England & Wales
    CIF 1
    Limited By Shares in Companies House, England And Wales
    CIF 2 CIF 3
child relation
Offspring entities and appointments
Active 3
  • 1
    Olliver, Aske, Richmond, North Yorkshire, England
    Dissolved Corporate (4 parents)
    Equity (Company account)
    1 GBP2020-10-31
    Person with significant control
    2021-02-24 ~ dissolved
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Right to appoint or remove directors → OE
  • 2
    Olliver, Aske, Richmond, North Yorkshire, England
    Dissolved Corporate (3 parents)
    Equity (Company account)
    100 GBP2020-09-30
    Person with significant control
    2021-02-11 ~ dissolved
    CIF 3 - Ownership of shares – 75% or more → OE
    CIF 3 - Ownership of voting rights - 75% or more → OE
    CIF 3 - Right to appoint or remove directors → OE
  • 3
    Olliver, Aske, Richmond, North Yorkshire, England
    Dissolved Corporate (4 parents)
    Equity (Company account)
    -2,918 GBP2021-02-28
    Person with significant control
    2021-02-11 ~ dissolved
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.